The global ophthalmic ultrasound devices market size valued at USD 456.4 million in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 6.1% from 2019 to 2026. The growing prevalence of ophthalmic diseases such as diabetic retinopathy & cataract and frequent launch of products are among the factors driving the market growth.
Ocular ultrasound continues to be an integral diagnostic tool in ophthalmology as it has significant applications including visualization of posterior eye segment in dense cataract or vitreous hemorrhage conditions. Common usage of ophthalmic ultrasound devices includes measuring the focal length to determine the power of the corrective lens, visualizing lens dislocation, detecting choroidal melanoma & retinal detachments, and diagnosing other ophthalmic disorders.
Growing incidence of lifestyle & age-related ophthalmic conditions and an increasing number of specialty eye care clinics in developing regions are among the factors expected to boost market demand over the forecast period. As per WHO, the number of people suffering from diabetes has increased to 422 million in 2014 from 108 million in 1980. Diabetic retinopathy is observed in one out of three patients and is one of the major causes of blindness.
According to the National Eye Institute, the number of people suffering from cataracts in the U.S. is expected to reach about 40 million in 2030. Surgery, the only effective treatment for cataract, is performed only after ocular ultrasound imaging to determine the power of the corrective lens. Imaging is also done postsurgery to ensure that lens is perfectly placed, signifying the potential of ophthalmic ultrasound devices.
Rise in the number of initiatives to improve access to cataract treatment in rural areas of developed as well as developing regions is expected to increase the demand for ophthalmic ultrasound systems. For instance, the National Programme for Control of Blindness (NPCB) is one of the initiatives focused on providing eye care services for the underserved patient pool, strengthening of human resources in the field of ophthalmology and development of sustainable infrastructure.
The ocular ultrasound devices market is segmented based on product type into A-scan, B-scan, combined, pachymeter, and ultrasound biomicroscope. The A-scan segment held the largest share in 2018. High usage of A-scan devices for preoperative visualization of a detached retina in conditions such as vitreous hemorrhage, periorbital trauma, or lens opacification is one of the major factors driving growth. A-scans have significant benefits in cataract surgeries. The segment is expected to exhibit lucrative growth in the coming years.
The combination devices segment is expected to grow at the fastest rate during the forecast period. Improving the reach of these compact, affordable, lightweight, and multifunctional devices is expected to fuel segment growth. The increasing number of local manufacturers in developing countries, such as India, China, and South Korea, is expected to have a significantly high impact on segment growth in the global market. Local manufacturers provide advanced products at competitive prices on a global platform. This is expected to result in various strategic initiatives by major players to retain their market position.
Based on end-use, the global ophthalmic ultrasound device market is segmented into hospitals, ambulatory surgical centers, and ophthalmic clinics. The hospital segment accounted for the largest share in 2018. Favorable government policies for the development of eye care facilities in different geographies is one of the major factors that can be attributable to this share. Significant patient pool, availability of advanced technology, and favorable government programs are the factors driving the segment growth.
A growing number of ophthalmologists in developing countries are expected to have a significant impact on growth, with a resultant increase in the number of ophthalmic clinics. An increase in ease of doing business and favorable government initiatives in countries such as India, Netherlands, Thailand, Philippines, and China is expected to fuel segment growth during the forecast period.
Based on mobility, the global ophthalmic ultrasound systems market is segmented into portable/handheld and standalone devices. Standalone devices held the largest share in 2018, owing to factors such as easy availability, affordability, and easy handling. The popularity of standalone devices is expected to decline over the forecast period with the introduction of advanced, accurate handheld systems.
Space constraints in ophthalmologist clinics, the ongoing introduction of portable ocular ultrasound devices with advanced features at affordable pricing, and improving the standard of healthcare around the globe are expected to aid the growth of this segment. With the high demand for portable devices, major players are offering exchange offers on standalone devices, boosting segment growth. As a result, this segment is expected to exhibit the fastest growth during the forecast period.
North America dominated the ophthalmic ultrasound devices market owing to high demand for technologically advanced medical instruments, such as A-scan, B-scan, & combined devices, largely due to the increasing prevalence of diabetes in the region. Besides, the presence of a large number of global players and suppliers also can be attributed to the largest share.
Europe accounted for the second-largest share in the market in 2018. Presences of a large number of ophthalmology societies such as the European Society of Ophthalmology (ESC) and European Society of Cataract and Refractive Surgeons to promote the study and practice of modern ophthalmology is one of the major drivers. ESC, as a part of their yearly activities, will be conducting an event for “ophthalmic imaging from theory to current practice congress” in Oct 2019 at Paris, aiding segment growth.
Asia Pacific is also anticipated to grow at a significant CAGR over the forecast period, due to high unmet needs and developing healthcare infrastructure, especially in India and China. Furthermore, the presence of local manufacturers & suppliers and the rise in prevalence of ophthalmic disorders are expected to aid the growth of the region.
The players are focusing on various growth strategies such as frequent product launches, innovations in existing products, and mergers & acquisitions. For instance, in March 2019, Quantel Medical received U.S.FDA approval for its product ABSolu that provides A/B/S/UBM ultrasound technology with exceptional image quality in one device. Some of the prominent players in the ophthalmic ultrasound devices market include:
Halma plc
NIDEK CO. LTD.
Quantel Medical
Optos
Escalon Medical Corp
Appasamy associates
MicroMedical devices
DGH technology
Ellex
Carl Zeis Meditech
Report Attribute |
Details |
The market size value in 2020 |
USD 508.2 million |
The revenue forecast in 2026 |
USD 728.7 million |
Growth Rate |
CAGR of 6.1% from 2019 to 2026 |
The base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, end-use, mobility, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; India; Japan; Thailand; South Korea Mexico; Brazil; Colombia; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Halma plc; NIDEK CO. LTD.; Quantel Medical; Optos; Escalon Medical Corp; Appasamy associates; MicroMedical devices; DGH technology; Ellex; Carl Zeis Meditech |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For this study, Grand View Research has segmented the global ophthalmic ultrasound devices market report based on the product, end-use, mobility, and region:
Product Outlook (Volume, ‘000 Units; Revenue, USD Million, 2015 - 2026)
A-Scan
B-Scan
Combined
Pachymeter
Ultrasound biomicroscope
End-use Outlook (Revenue, USD Million, 2015 - 2026)
Hospital
Ambulatory research centers
Ophthalmic clinic
Others
Mobility Outlook (Revenue, USD Million, 2015 - 2026)
Standalone
Portable/ Handheld
Regional Outlook (Revenue, USD Million, 2015 - 2026)
North America
The U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
Japan
India
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global ophthalmic ultrasound market size was estimated at USD 481.5 million in 2019 and is expected to reach USD 508.2 million in 2020.
b. The global ophthalmic ultrasound market is expected to grow at a compound annual growth rate of 6.1% from 2019 to 2026 to reach USD 728.7 million by 2026.
b. North America dominated the ophthalmic ultrasound market with a share of 38.1% in 2019. This is attributable to growing demand for technologically advanced medical instruments such as A-scan, B-scan and combined devices largely due to increasing prevalence of diabetes.
b. Some key players operating in the ophthalmic ultrasound market include Halma plc, NIDEK CO. LTD., Quantel Medical, Optos, Escalon Medical Corp, Appasamy associates, MicroMedical devices, DGH technology, Ellex, Carl Zeis Meditech.
b. Key factors that are driving the market growth include technological advancements, increasing cases of ophthalmic disorders, and growing number of product launch.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.